---
title: "Purple Biotech (PPBT.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/PPBT.US/norm.md"
symbol: "PPBT.US"
name: "Purple Biotech"
parent: "https://longbridge.com/zh-CN/quote/PPBT.US.md"
datetime: "2026-05-21T05:57:50.256Z"
locales:
  - [en](https://longbridge.com/en/quote/PPBT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PPBT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PPBT.US/norm.md)
---

# Purple Biotech (PPBT.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.1840 | -19.77 | -2.86 | -3.96 | -1.72 |
| ROE | -3.54% | -443.34% | -16.09% | -13.43% | -5.53% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -86000.00 | -23.55M | -1.30M | -1.08M | -453000.00 |
| 营业利润 | -2.25M | -2.96M | -1.37M | -1.24M | -1.41M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 14.42M | 17.57M | 39.06M | 34.38M | 35.59M |
| 权益乘数 | 1.49 | 1.82 | 1.19 | 1.07 | 1.09 |
| 每股净资产 | 20.89 | 10.45 | 71.95 | 116.97 | 124.03 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 6.43M | 9.57M | 10.45M | 5.92M | 7.09M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 278000.00 | 346000.00 | 445000.00 | 223000.00 | 237000.00 |
| 净债务 | -6.24M | -9.33M | -10.20M | -5.82M | -6.95M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -3.12M | -1.07M | -1.07M | -1.54M | -1.98M |
| 投资现金流 | 45000.00 | -104000.00 | 372000.00 | 107000.00 | 257000.00 |
| 融资现金流 | -64000.00 | 297000.00 | 5.57M | 366000.00 | 103000.00 |
| 自由现金流 | -4.50M | -157875.00 | 3.04M | -1.17M | -1.97M |
| 现金流充裕率 | -5289.83% | -1667.19% | -1720.97% | -3765.85% | -3732.08% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -3000.00 | 2000.00 | -2000.00 | - |